Website visits
39.6K /mo.
Mentions
118
Overview
Employees
501-1000
Founded date
1994
Mentions in press and media 118
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 1, 2026 | Swings in the bond market shake stock markets worldwide, as AI optimism supports Wall Street | Getting your Trinity Audio player ready... By STAN CHOE, AP Business Writer NEW YORK (AP) — More swings in the bond market are rattling stock markets around the world on Thursday. On Wall Street, the moves were relatively modest after U.S. ... |
| Aug 17, 2026 | Leal Therapeutics Raises $30M in Second Close of Series A Funding | Leal Therapeutics, a Worcester, MA-based provider of neuro-metabolic therapeutics for central nervous system disorders, raised $30M in the second close of its Series A funding. Backers included Eli Lilly and Company, OrbiMed, Newpath Partne... |
| Aug 13, 2026 | Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs | Khartis Therapeutics Raises $50M Series B Khartis Therapeutics has raised $50 million in Series B funding to advance its oral medicine pipeline.mForge Life Science Partners led the round. Longwood Fund and Alexandria Venture Investments joi... |
| Jul 1, 2026 | - | In honor of America's enduring legacy of patriotism, courage and service, Alexandria highlights the impact of its mission-critical partnership and support of the National Medal of Honor Museum Foundation. From citizen-soldiers who fou... |
| Jun 22, 2026 | Vedana Therapeutics Raises $46M in Series A Funding | Vedana Therapeutics, a Seattle, WA-based biotechnology company developing new therapies for migraine prevention, raised $46M in Series A funding. The round was led by Westlake BioPartners and Canaan Partners, with participation from Dawn Bi... |
| Jun 19, 2026 | Vedana Therapeutics Raises $46 Million To Advance Next-Generation Migraine Therapies | Vedana Therapeutics emerged from stealth with $46 million in Series A funding to advance next-generation therapies for migraine prevention. The funding round was co-led by Westlake BioPartners and Canaan Partners, with participation from Da... |
| Jun 16, 2026 | SonoThera Secures $125M: Ultrasound Reshapes Genetic Medicine | SonoThera, a biotechnology pioneer, just closed a significant Series B funding round. The South San Francisco-based firm secured $125 million. This oversubscribed financing fuels its revolutionary nonviral genetic medicine platform. The inv... |
| Jun 10, 2026 | SonoThera Raises $125 Million Series B To Advance Ultrasound-Mediated Genetic Medicines | SonoThera, a biotechnology company developing ultrasound-mediated nonviral genetic medicines, announced the closing of an oversubscribed $125 million Series B financing round to support the clinical advancement of its lead programs for Duch... |
| Jun 10, 2026 | SonoThera Raises $125M in Series B Funding | SonoThera, a South San Francisco, CA-based biotechnology company developing new genetic medicines, raised $125M in Series B funding. The round was led by Vida Ventures, with participation from ARK Invest, CureDuchenne Ventures, Leaps by Bay... |
| May 14, 2026 | Create Medicines Raises $122M in Series B Funding | Create Medicines, Inc., a Cambridge, Massachusetts-based developer of in vivo immune programming and mRNA-LNP cell therapies, raised $122m in Series B funding. The round was co-led by existing investors Newpath Partners, ARCH Venture Partne... |
| Nov 12, 2025 | AI-Driven Biotech Iambic Secures Over $100M for Drug Discovery | Iambic, a San Diego AI-driven biotech, secured over $100M in funding. This capital fuels its advanced AI drug discovery platform and expanding clinical pipeline. The company rapidly advances novel therapies, like IAM1363, showing strong ant... |
| Nov 11, 2025 | Iambic Raises Over $100M in Funding | Iambic, a San Diego, CA-based clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, raised over $100M in funding. Backers included Abingworth, Alexandria Ventur... |
| Nov 8, 2025 | Accipiter Biosciences Secures $12.7M Seed Funding, Revolutionizing Protein Therapies | Accipiter Biosciences, a Seattle biotech, exited stealth with $12.7 million in seed funding. The company pioneers de novo multifunctional protein therapeutics. Its computational platform designs novel biologics from scratch. These single mo... |
| Nov 7, 2025 | Accipiter Biosciences: $12.7 Million Seed Funding Closed To Develop De Novo Protein Therapies | Accipiter Biosciences has emerged from stealth with $12.7 million in seed funding to advance a new class of de novo multifunctional protein therapeutics designed to treat complex diseases. The seed round was co-led by Takeda and Flying Fish... |
| Oct 22, 2025 | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion | EQT Life Sciences’ ImCheck Therapeutics to be acquired by Ipsen in a transaction valued at up to EUR 1 billion Wed, Oct 22, 2025 09:20 CET Report this content Ipsen and ImCheck Therapeutics have entered into a definitive share purchase agre... |
| Oct 17, 2025 | Affinia Therapeutics: $40 Million Series C Raised For Advancing Gene Therapies For Cardiovascular And Neurological Diseases | Affinia Therapeutics, a biotechnology company pioneering engineered adeno-associated virus (AAV) gene therapies for severe cardiovascular and neurological conditions, has announced the closing of a $40 million Series C financing round. The ... |
| Oct 15, 2025 | Nilo Therapeutics Secures $101M for Neuro-Immunology Revolution | Nilo Therapeutics launched with $101 million Series A funding. The neuro-immunology biotech seeks to restore immune balance. It modulates neural circuits, targeting autoimmune and inflammatory diseases. Key investors include The Column Grou... |
| Oct 9, 2025 | Nilo Therapeutics Raises $101M in Series A Financing | Nilo Therapeutics, a NYC-based biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched with a $101m Series A financing. The round was led by The Column Group (TCG), DCVC Bio, and Lux Capital, with... |
| Oct 8, 2025 | Immunology biotech Nilo launches with $101M and mission to harness neural circuits | Nilo Therapeutics has launched with $101 million in series A funds to drive its ambition to harness neural circuits to restore immune homeostasis. The New York-headquartered company was founded by a trio of respected academics in Columbia U... |
| Oct 1, 2025 | Crystalys Therapeutics: $205 Million Series A Raised For Transforming Gout Treatment | Crystalys Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for gout, a condition characterized by high levels of uric acid in the blood that can lead to painful arthritis flare-ups. The... |
| Sep 30, 2025 | Crystalys Therapeutics Raises in $205M Series A Funding | Crystalys Therapeutics, a San Diego, CA-based clinical-stage biopharmaceutical company, raised $205M in Series A funding. The round was led by Novo Holdings, SR One and Catalys Pacific with participation from a broad syndicate of investors,... |
| Sep 12, 2025 | Congruence Therapeutics: $32 Million Financing Raised For Advancing Genetic Obesity Therapy | Congruence Therapeutics has secured a $32 million financing round to support the development of its lead candidate CGX-926, the first clinical therapy designed to treat MC4R-deficient genetic obesity. The proceeds will fund a Phase 1 trial ... |
| Aug 30, 2025 | Leal Therapeutics: $30 Million Series A Secured To Advance Breakthrough CNS Therapies | Leal Therapeutics, a biotechnology company pioneering novel treatments for central nervous system (CNS) disorders, has announced the closing of a $30 million Series A financing round. The round was led by SV Health Investors’ Dementia Disco... |
| Jul 25, 2025 | Dispatch Bio Launched With $216 Million To Develop Solid Tumor Treatments | Dispatch Bio has officially launched with a mission to create a universal treatment for solid tumors, which constitute roughly 90% of cancers. The company has secured a total of $216 million in funding, including a recent Series A round. Th... |
| Jul 24, 2025 | Dispatch Bio Raises Series A in Funding; Total To $216M | Dispatch Bio, a San Francisco, CA- and Philadelphia, PA-based Biotechnology company developing treatments for tumours, raised an undisclosed amounting Series A funding. Backers included ARCH Venture Partners and PICI, along with Bristol Mye... |
| Jun 4, 2025 | The Shifting Landscape of Office Space: A New Era in Commercial Real Estate | The office space market is undergoing a seismic shift. For the first time in over 25 years, more office space is being removed than added. This trend marks a pivotal moment in the commercial real estate sector. The pandemic has left its mar... |
| Jun 4, 2025 | The Shifting Landscape of Commercial Real Estate: A Tale of Transformation | The commercial real estate market is undergoing a seismic shift. For the first time in decades, more office space is being removed than added. This change is not just a statistic; it’s a reflection of evolving work habits and economic reali... |
| Jun 2, 2025 | More office space is being removed than added for the first time in at least 25 years | More office space is set to be removed than added this year, shrinking the overall office footprint. Office vacancies soared to a record high and still hover right around there at 19%. Developers also have another 85 million square feet of ... |
| May 8, 2025 | HAYA Therapeutics: Pioneering the Future of RNA-Guided Therapies | In the world of biotechnology, innovation is the lifeblood. HAYA Therapeutics has just secured a hefty $65 million in Series A funding, a financial boost that could change the landscape of chronic and age-related disease treatment. This fun... |
| May 8, 2025 | HAYA Therapeutics banks $65 million Series A funding | HAYA Therapeutics is a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common, chronic and age-related diseases. The core of HAYA’s proprie... |
| Apr 28, 2025 | Morning Bid: The toll from Trump's tariffs | Morning Bid: The toll from Trump's tariffs By Mike DolanApril 28, 202510:52 AM UTCUpdated ago Text Small Text Medium Text Large Text Share X Facebook Linkedin Email Link CommentaryBy Mike Dolan A futures-options trader works on the flo... |
| Apr 2, 2025 | Artis BioSolutions Raises Funding; Acquires Landmark Bio | Artis BioSolutions, a San Diego, CA-based company which specializes in the development and production of genetic medicines, raised an undisclosed amount in funding. The round was led by Oak HC/FT. The company intends to use the funds to fur... |
| Mar 6, 2025 | Exclusive: AI-powered plant breeding startup Avalo raises $11m, partners with Coca Cola to future proof sugarcane production | Avalo—a startup deploying interpretable artificial intelligence to develop climate resilient crops—has raised an $11 million Series A round and entered into a partnership with CCEP to futureproof its sugarcane supply chain and reduce scope ... |
| Sep 10, 2024 | Alexandria Real Estate Equities, Inc. Executive Chairman and Founder Joel S. Marcus to Be Honored With the Inaugural Bisnow Life Sciences Icon & Influencer Award | PASADENA, Calif., Sept. 10, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative mega campuses in AAA life science innov... |
| Aug 15, 2024 | Lilly's New Innovation Center: A Beacon for Biotech in Boston | Eli Lilly and Company has unveiled a new chapter in its storied history with the opening of the Lilly Seaport Innovation Center (LSC) in Boston. This state-of-the-art facility is not just a building; it’s a lighthouse guiding the future of ... |
| Aug 13, 2024 | Lilly opens state-of-the-art research and development center in the Boston Seaport | Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs New 346,000 square foot facility will accommodate approximately 500 Lilly scientis... |
| Aug 3, 2024 | Outpace Bio: A New Dawn in Cancer Treatment with AI-Powered Cell Therapies | In the realm of cancer treatment, innovation is the lifeblood. Outpace Bio is injecting fresh vigor into this field with its recent $144 million Series B financing. This funding, led by RA Capital Management, is a beacon of hope for patient... |
| Aug 1, 2024 | Outpace Bio Secures $144M for AI-Powered Cell Therapy Platform | What You Should Know: – Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including Qatar Investment ... |
| Jul 29, 2024 | Deals in brief: Hive Health raises USD 6.5 million, AgFunder VC closes fourth early-stage fund, ten China and India deals, and more | Hive Health raises USD 6.5 million in pre-Series A round Hive Health, a health insurance company based in Manila, has raised USD 6.5 million in a pre-Series A funding round. Key investors include Gentree Fund and Beenext, with participation... |
| Jun 17, 2024 | Bright Peak Therapeutics raises USD90 million to advance lead program into clinical trials | Bright Peak Therapeutics is a biotechnology company advancing a portfolio of multifunctional immunotherapies to treat cancer and other diseases. “We are now well positioned to bring much needed innovation to the field of anti-PD-1 immune-c... |
| May 22, 2024 | Exploring real estate investment opportunities abroad? Know key risks here | |
| May 6, 2024 | OverT Bio Secures $16M to Optimize Cell Therapy for Solid Tumors | What You Should Know: – OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing VC, the round saw participa... |
| Mar 11, 2024 | Umaro Foods: Seaweed Bacon Revolution | Umaro Foods, the Californian plant-based meat producer, has secured $3.8 million in funding to launch its innovative seaweed bacon into supermarkets. Led by AgFunder, the financing round aims to reduce production costs and expand the reach ... |
| Mar 6, 2024 | Umaro Foods raises $3.8m in new financing as it scales up meat-free bacon ‘at half the cost’ of animal bacon | [Disclosure: AgFunderNews’ parent company, AgFunder, is an investor in Umaro Foods.] Umaro Foods has raised $3.8m in new financing including a seed 2 equity round led by AgFunder and grant funding as it gears up to launch its seaweed-based ... |
| Feb 9, 2024 | Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics | 09/02/2024 Nota de prensa YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond... |
| Jan 24, 2024 | Elo Life Systems raises $20.5m in series A2, aims to launch natural sweetener in 2026: ‘Everyone is trying to reduce sugar’ | North Carolina-based Elo Life Systems has closed a $20.5 million Series A2 round to accelerate the development of a natural high-intensity sweetener and Cavendish bananas engineered to resist the devastating Fusarium wilt fungal disease (TR... |
| Oct 25, 2023 | Developer delivers 120-square-foot life science innovation hub to The Woodlands | A new innovation hub mega campus has opened in The Woodlands. The Alexandria Center for Advanced Technologies at The Woodlands comes courtesy of California-based Alexandria Real Estate Equities Inc. The campus is home to the first purpose-b... |
| Aug 22, 2022 | Seattle startup aiming to detect, treat Alzheimer’s and Parkinson’s disease raises cash | AltPep CEO and founder Valerie Daggett. (AltPep Photo) The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valeri... |
| Aug 10, 2022 | The women writing checks: A list of female venture capitalists in the Pacific Northwest | Back in 2018, GeekWire published a list of women investors based in the Pacific Northwest who were writing checks to help startups grow. A lot has changed in four years. We’ve put together a new compilation below, highlighting more than 60 ... |
| Jun 10, 2022 | The Navy SEAL Foundation Honors Los Angeles Rams Owner/Chairman Stanley Kroenke with Patriot Award | Los Angeles Rams Owner/Chairman E. Stanley Kroenke and Navy SEAL Foundation CEO Robin King at the NSF Los Angeles Evening of Tribute To the Navy SEALS, we are grateful for your incredible bravery and selflessness, and we appreciate your tre... |
| May 9, 2022 | BREAKING: Brightseed bags $68m Series B funding from Temasek, AgFunder, others to launch ingredients biz | Disclosure: AFN’s parent company, AgFunder, is an investor in Brightseed. US nutrient discovery company Brightseed has raised $68 million in funding as it scales up its novel ingredients business. Singapore sovereign fund Temasek led the Se... |
| Apr 1, 2022 | Umaro’s $3m AgFunder-led seed round hints at a ocean-based future for alternative protein | Disclosure: AFN’s parent company, AgFunder, is an investor in Umaro Foods. California’s Umaro Foods has raised $3 million in seed funding for its technology that turns seaweed into a protein source and functional ingredient for meat analogs... |
| Mar 24, 2022 | The Week in Agrifoodtech: African startups Apollo, Wasoko & ThriveAgric close big-ticket rounds | This has been a watershed week for African agrifoodtech, with a string of startups from the continent closing eight and nine-figure US dollar rounds over the past few days. Kenya’s Wasoko and Apollo Agriculture raised $125 million and $40 m... |
| Mar 22, 2022 | AgFunder captures increasing, urgent investor demand for agrifoodtech with $60m Fund IV first close | Disclosure: AgFunder is AFN’s parent company. AgFunder, one of the world’s most active investors in foodtech and agtech startups, has increased its assets under management to $160 million – 10x in two years – with the first close of its fou... |
| Feb 3, 2022 | Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $800,000,000 of Senior Notes due 2034 $1,000,000,000 of Senior Notes due 2052 | PASADENA, Calif., Feb. 2, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public offering of $800,000,000 aggregate principal am... |
| Feb 2, 2022 | Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes | PASADENA, Calif., Feb. 2, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering, subject to market co... |
| Jan 28, 2022 | Alexandria Venture Investments Commits Over $100M to Climate Change Technology Related Investments in 2021 | PASADENA, Calif., Jan. 28, 2022 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| Jan 27, 2022 | Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2021 Distributions | PASADENA, Calif., Jan. 27, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced the tax treatment of its year 2021 distributions as described in the chart below. Stockholders are encouraged to consult with ... |
| Jan 19, 2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES UNDERWRITERS' EXERCISE AND CLOSING OF OPTION TO PURCHASE ADDITIONAL 1,050,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 18, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that the underwriters of its previously announced underwritten public offe... |
| Jan 11, 2022 | Alexandria Venture Investments Achieves Fifth Consecutive Annual #1 Most Active Corporate Investor in Biopharma | PASADENA, Calif., Jan. 10, 2022 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| Jan 8, 2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF 7,000,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 7, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the closing of its previously announced underwritten public offering of 7,0... |
| Jan 5, 2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF 7,000,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 4, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of 7,000,000 shares of the Compa... |
| Jan 5, 2022 | ALEXANDRIA REAL ESTATE EQUITIES, INC. ANNOUNCES PUBLIC OFFERING OF 6,500,000 SHARES OF COMMON STOCK | PASADENA, Calif., Jan. 4, 2022 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering of 6,500,000 shares o... |
| Dec 14, 2021 | Alexandria Real Estate Equities, Inc. Enhances Its Pioneering Social Responsibility Initiatives by Enabling the Non-Profit Camp Kita to Further Its Mission to Support Children Impacted by Suicide | PASADENA, Calif., Dec. 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| Nov 30, 2021 | Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2021 Operating and Financial Results Conference Call and Webcast on February 1, 2022 | PASADENA, Calif., Nov. 30, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, February 1, 2022, at 3:00 p.m. Eastern Time (ET)... |
| Nov 29, 2021 | Alexandria Venture Investments Ramps Investment Activity | Pasadena-based Alexandria Venture Investments, the venture arm of Alexandria Real Estate Equities, says that has been ranked as one of the year's top five most active U.S. investors in the "agrifoodtech" sector. According to ... |
| Nov 29, 2021 | Alexandria Venture Investments, One of the Year's Top Five Most Active U.S. Investors in Agrifoodtech, Accelerates Its Mission-Critical Investment Activity in a Sector Experiencing Tremendous Upsurge in Venture Funding | PASADENA, Calif., Nov. 29, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering ... |
| Nov 16, 2021 | Alexandria Real Estate Equities, Inc. Is Leading the Integration of Mission-Critical R&D and Next-Gen Manufacturing for Companies in Research Triangle That Are Developing Targeted Gene and Cell Therapies and Other Complex Medicines | PASADENA, Calif. and DURHAM, N.C., Nov. 16, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collabo... |
| Nov 5, 2021 | Alexandria Real Estate Equities, Inc. to Join the National Medal of Honor Museum Foundation at Dallas Cowboys' 'Salute to Service' Game, to Celebrate the Company's Long-Term Support and Raise Awareness for the Future National Museum and Its Mission | PASADENA, Calif., Nov. 5, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scienc... |
| Oct 25, 2021 | Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 3Q21 and YTD 3Q21 Net Income per Share - Diluted of $0.67 and $3.38, respectively; 3Q21 and YTD 3Q21 FFO per Share - Diluted, ... | PASADENA, Calif., Oct. 25, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2021. Key highlights YTD Operating results 3Q21 3Q20 3Q21 3... |
| Oct 18, 2021 | Alexandria Real Estate Equities : Venture Investments Maintains Recognition as #1 Most Active Early-Stage Life Science Investor | PASADENA, Calif., Oct. 18, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE:ARE), an urban office REIT and the first, longest-tenured and pioneering o... |
| Oct 15, 2021 | Alexandria Real Estate Equities, Inc. : Recognized for Continued ESG Leadership and Performance in the 2021 GRESB Assessment | PASADENA, Calif., Oct. 15, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| Sep 30, 2021 | Alexandria Real Estate Equities, Inc. : Deepens and Expands Strategic Relationship With Moderna for New 462,000 RSF HQ and R&D Facility at 325 Binney Street, Designed to Be the Most Sustainable Laboratory Building in Cambridge | PASADENA, Calif. and CAMBRIDGE, Mass., Sept. 30, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on co... |
| Sep 1, 2021 | The Week in Agrifoodtech: Toast files for IPO, Pinduoduo commits $1.5bn to ag | In news from the world of foodtech and agtech over the past seven days, restaurant payments platform Toast filed for an IPO in the US; while VC firm AgFunder closed its latest alt-protein fund, New Carnivore, on $21 million [disclosure: AgF... |
| Aug 31, 2021 | Alexandria Real Estate Equities, Inc. : to Hold Its Third Quarter 2021 Operating and Financial Results Conference Call and Webcast on October 26, 2021 | PASADENA, Calif., Aug. 31, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, October 26, 2021, at 3:00 p.m. Eastern Time (ET)... |
| Aug 26, 2021 | AgFunder raises $21m for New Carnivore alt-protein fund from ADM, Alexandria & others | Disclosure: AgFunder is AFN’s parent company. Agrifoodtech VC AgFunder has announced the final close of New Carnivore, its alternative protein fund, on $21 million. The fund was oversubscribed, surpassing its hard cap. ADM Ventures, the VC ... |
| Aug 5, 2021 | AgFunder exit review: John Deere’s $250m acquisition of Bear Flag Robotics | Editor’s note: Bear Flag Robotics, an agtech startup focused on automation, has been acquired by John Deere for $250 million. Bear Flag Robotics was a portfolio company of agrifoodtech VC AgFunder, which is AFN’s parent company. Here, AgFun... |
| Aug 5, 2021 | AgFunder exit review: John Deere’s $250m acquisition of Bear Flag Robotics | Editor’s note: Bear Flag Robotics, an agtech startup focused on automation, has been acquired by John Deere for $250 million. Bear Flag Robotics was a portfolio company of agrifoodtech VC AgFunder, which is AFN’s parent company. Here, AgFun... |
| Jun 29, 2021 | Alexandria Real Estate Equities, Inc. : Releases 2020 ESG Report Highlighting Its Pioneering Sustainability and Social Impact Leadership | PASADENA, Calif., June 29, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| Jun 22, 2021 | Alexandria Real Estate Equities, Inc. : Announces Underwriters' Exercise And Closing Of Option To Purchase Additional 1,050,000 Shares Of Common Stock | PASADENA, Calif., June 22, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that the underwriters of its previously announced underwritten public offe... |
| Jun 17, 2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. : Announces Closing of Public Offering of 7,000,000 Shares of Common Stock | PASADENA, Calif., June 17, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the closing of its previously announced underwritten public offering of 7,... |
| Jun 15, 2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. : Announces Pricing Of Upsized Public Offering Of 7,000,000 Shares Of Common Stock | PASADENA, Calif., June 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public offering of 7,000,000 shares of the Comp... |
| Jun 14, 2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. : Announces Public Offering Of 6,500,000 Shares Of Common Stock | PASADENA, Calif., June 14, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it is commencing an underwritten public offering of 6,500,000 shares ... |
| Jun 14, 2021 | Bright Peak Therapeutics Closes $107 Million Financing Round | |
| May 25, 2021 | BREAKING: Invaio raises $89m to accelerate commercialization of its injectable bio-inputs | Invaio Sciences has raised $88.9 million in a Series C round led by venture builder Flagship Pioneering, which launched the startup in 2018. Other investors joining the round include Stage 1 Ventures, Bluwave Capital, and Alexandria Venture... |
| May 25, 2021 | Invaio raises $89m to accelerate commercialization of its injectable bio-inputs | Invaio Sciences has raised $88.9 million in a Series C round led by venture builder Flagship Pioneering, which launched the startup in 2018. Other investors joining the round include Stage 1 Ventures, Bluwave Capital, and Alexandria Venture... |
| May 25, 2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. : to Hold Its Second Quarter 2021 Operating and Financial Results Conference Call and Webcast on July 27, 2021 | PASADENA, Calif., May 25, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, July 27, 2021, at 3:00 p.m. Eastern Time (ET), in... |
| Apr 26, 2021 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. Reports: 1Q21 Net Income per Share - Diluted of $0.04; 1Q21 FFO per Share - Diluted, As Adjusted, of $1.91; and Alexandria at the Vanguard and Heart of the Life Science Ecosystem | PASADENA, Calif., April 26, 2021 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the first quarter ended March 31, 2021. Key highlights Operating results 1Q21 1Q20 Total revenue... |
| Mar 12, 2021 | Brief: Alexandria REIT to form $250m agrifoodtech SPAC | Alexandria Agtech/Climate Innovation Acquisition, a special purpose acquisition company (SPAC) formed by US real estate investment trust Alexandria Real Estate Equities, has filed with the US Securities & Exchange Commission to raise up... |
| Mar 12, 2021 | Brief: Alexandria REIT to form $313m agrifoodtech SPAC | Alexandria Agtech/Climate Innovation Acquisition, a special purpose acquisition company (SPAC) formed by US real estate investment trust Alexandria Real Estate Equities, has filed with the US Securities & Exchange Commission to raise up... |
| Nov 16, 2020 | Alexandria Real Estate Equities, Inc. : Achieves the World's First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City | PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| Nov 16, 2020 | ALEXANDRIA REAL ESTATE EQUITIES, INC. Alexandria Real Estate Equities, Inc. : Achieves the World's First WELL Health-Safety Rating for Laboratory Space at Alexandria LaunchLabs in New York City | PASADENA, Calif., Nov. 16, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life scien... |
| Jul 2, 2020 | TerMir wins Alexandria’s inaugural AgTech Innovation Prize | Our mission at Alexandria Real Estate Equities, Inc. (NYSE: ARE) is to create and cultivate collaborative, innovation clusters that enable breakthroughs to advance human health and improve nutrition; this mission is now more important than ... |
| Feb 20, 2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| Jan 15, 2020 | Alexandria LaunchLabs opens $100k agtech pitch competition – apply by Jan 31! | Are you an agtech entrepreneur looking for a little capital to take your idea to the next level? Alexandria LaunchLabs – AgTech is looking for early-stage startups to compete in an expenses-paid, in-person pitch competition in North Carolin... |
| Apr 1, 2019 | Alexandria Absorbs AgTech Accelerator into Seed Capital Platform and LaunchLabs in RTP | Alexandria Real Estate Equities, the real estate investment trust (REIT) focused on life sciences and technology campuses, has launched a multi-faceted agtech investment strategy including physical facilities for agtech businesses to operat... |
| Sep 24, 2018 | MouSensor Closes a $3.3M Seed Round | MouSensor, Inc., a biotechnology company that develops a novel and potentially transformative platform to digitize the sense of smell, announced today that it has raised $3.3M in its seed round. The seed round was co-led by imec.xpand and A... |
| Sep 23, 2018 | Celgene Joins $47.5M Series A for Silverback Therapeutics | Silverback Therapeutics, Inc., a biotechnology company developing a pipeline of systemically delivered, locally active therapies, has closed an extension of its Series A financing to bring the total raised in the round to $47.5 million. The... |
| Sep 19, 2018 | Silverback Therapeutics raises $37.5M, unveils tech that targets therapies to disease locations | Peter Thompson, co-founder and CEO of Silverback Therapeutics. (OrbiMed Advisors Photo) Silverback Therapeutics, a stealthy biotechnology startup, gave the first glimpse of its technology Wednesday as it announced an additional $37.5 millio... |
Show more
Reviews 0
FAQ about Alexandra Real Estate Equities
When was Alexandra Real Estate Equities founded?
Alexandra Real Estate Equities was founded in 1994.
What has the press written about Alexandra Real Estate Equities?
Parsers VC has collected 118 articles mentioning Alexandra Real Estate Equities, among them “Swings in the bond market shake stock markets worldwide, as AI optimism supports Wall Street” (Oct 1, 2026) and “Leal Therapeutics Raises $30M in Second Close of Series A Funding” (Aug 17, 2026).
Is Alexandra Real Estate Equities still active?
Yes, Alexandra Real Estate Equities is active; its latest activity on Parsers VC dates from Oct 26, 2026.